WCLC 2025 - Posters & ePosters-P1.11.85 Overall Survival With Nivolumab Plus Relatlimab With Platinum-Doublet Chemotherapy in Metastatic NSCLC From RELATIVITY-104

P1.11.85 Overall Survival With Nivolumab Plus Relatlimab With Platinum-Doublet Chemotherapy in Metastatic NSCLC From RELATIVITY-104

Asset Subtitle

Luis G. Paz-Ares

Meta Tag

Speaker Luis G. Paz-Ares

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy